These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 19922776)

  • 21. In-line monitoring of low drug concentration of flowing powders in a new sampler device.
    Sierra-Vega NO; Martínez-Cartagena PA; Alvarado-Hernández BB; Romañach RJ; Méndez R
    Int J Pharm; 2020 Jun; 583():119358. PubMed ID: 32335081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Process Analytical Technology approach to near-infrared process control of pharmaceutical powder blending. Part III: Quantitative near-infrared calibration for prediction of blend homogeneity and characterization of powder mixing kinetics.
    El-Hagrasy AS; Drennen JK
    J Pharm Sci; 2006 Feb; 95(2):422-34. PubMed ID: 16380973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Near-infrared spectral imaging for quality assurance of pharmaceutical products: analysis of tablets to assess powder blend homogeneity.
    Lyon RC; Lester DS; Lewis EN; Lee E; Yu LX; Jefferson EH; Hussain AS
    AAPS PharmSciTech; 2002; 3(3):E17. PubMed ID: 12916932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De-risking excipient particle size distribution variability with automated robust mixing: Integrating quality by design and process analytical technology.
    Lee WB; Widjaja E; Heng PWS; Chan LW
    Eur J Pharm Biopharm; 2020 Dec; 157():9-24. PubMed ID: 33022392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blend uniformity monitoring in a continuous manufacturing mixing process for a low-dosage formulation using a stream sampler and near infrared spectroscopy.
    Rangel-Gil RS; Nasrala-Álvarez JM; Romañach RJ; Méndez R
    Int J Pharm; 2024 Aug; 661():124478. PubMed ID: 39019300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput NIR-chemometric methods for determination of drug content and pharmaceutical properties of indapamide powder blends for tabletting.
    Porfire A; Rus L; Vonica AL; Tomuta I
    J Pharm Biomed Anal; 2012 Nov; 70():301-9. PubMed ID: 22884785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of tablet hardness based on near infrared spectra of raw mixed powders by chemometrics.
    Otsuka M; Yamane I
    J Pharm Sci; 2006 Jul; 95(7):1425-33. PubMed ID: 16721793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blend uniformity analysis using stream sampling and near infrared spectroscopy.
    Popo M; Romero-Torres S; Conde C; Romañach RJ
    AAPS PharmSciTech; 2002; 3(3):E24. PubMed ID: 12916939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raman spectroscopy as a process analytical technology (PAT) tool for the in-line monitoring and understanding of a powder blending process.
    De Beer TR; Bodson C; Dejaegher B; Walczak B; Vercruysse P; Burggraeve A; Lemos A; Delattre L; Heyden YV; Remon JP; Vervaet C; Baeyens WR
    J Pharm Biomed Anal; 2008 Nov; 48(3):772-9. PubMed ID: 18799281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. End point determination of blending process for trimebutine tablets using principle component analysis (PCA) and partial least squares (PLS) regression.
    Lee SH; Lee JH; Cho S; Do SH; Woo YA
    Arch Pharm Res; 2012 Sep; 35(9):1599-607. PubMed ID: 23054717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Process Analytical Technology approach to near-infrared process control of pharmaceutical powder blending. Part I: D-optimal design for characterization of powder mixing and preliminary spectral data evaluation.
    El-Hagrasy AS; D'Amico F; Drennen JK
    J Pharm Sci; 2006 Feb; 95(2):392-406. PubMed ID: 16381014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NIR Spectroscopy as an Online PAT Tool for a Narrow Therapeutic Index Drug: Toward a Platform Approach Across Lab and Pilot Scales for Development of a Powder Blending Monitoring Method and Endpoint Determination.
    Talwar S; Pawar P; Wu H; Sowrirajan K; Wu S; Igne B; Friedman R; Muzzio FJ; Drennen JK
    AAPS J; 2022 Sep; 24(6):103. PubMed ID: 36171513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting Blending End-Point Using Mean Squares Successive Difference Test and Near-Infrared Spectroscopy.
    Khorasani M; Amigo JM; Bertelsen P; Van Den Berg F; Rantanen J
    J Pharm Sci; 2015 Aug; 104(8):2541-9. PubMed ID: 26094601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP.
    Muselík J; Franc A; Doležel P; Goněc R; Krondlová A; Lukášová I
    Acta Pharm; 2014 Sep; 64(3):355-67. PubMed ID: 25296681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of near-infrared spectroscopy to quantify drug content on a continuous blending process: influence of mass flow and rotation speed variations.
    Martínez L; Peinado A; Liesum L; Betz G
    Eur J Pharm Biopharm; 2013 Aug; 84(3):606-15. PubMed ID: 23419815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of blend uniformity in a continuous tablet manufacturing process.
    Sierra-Vega NO; Román-Ospino A; Scicolone J; Muzzio FJ; Romañach RJ; Méndez R
    Int J Pharm; 2019 Apr; 560():322-333. PubMed ID: 30763679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of pharmaceutical powder blends by NIR chemical imaging.
    Ma H; Anderson CA
    J Pharm Sci; 2008 Aug; 97(8):3305-20. PubMed ID: 17948913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. THz-TDS as a PAT tool for monitoring blend homogeneity in pharmaceutical manufacturing of solid oral dosage forms: A proof-of-concept study.
    Anuschek M; Skelbæk-Pedersen AL; Skibsted E; Kvistgaard Vilhelmsen T; Axel Zeitler J; Rantanen J
    Int J Pharm; 2024 Sep; 662():124534. PubMed ID: 39079591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Near-infrared spectroscopy and imaging for the monitoring of powder blend homogeneity.
    El-Hagrasy AS; Morris HR; D'Amico F; Lodder RA; Drennen JK
    J Pharm Sci; 2001 Sep; 90(9):1298-307. PubMed ID: 11745782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparative Approach to Screen the Capability of Raman and Infrared (Mid- and Near-) Spectroscopy for Quantification of Low-Active Pharmaceutical Ingredient Content Solid Dosage Forms: The Case of Alprazolam.
    Makraduli L; Makreski P; Goracinova K; Stefov S; Anevska M; Geskovski N
    Appl Spectrosc; 2020 Jun; 74(6):661-673. PubMed ID: 32031007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.